Researchers from The Institute of Cancer Research found that Hsp90 inhibitors were effective in treating aggressive prostate cancer. The drug could target a network of cancer cell signals simultaneously.
Researchers from The Institute of Cancer Research found that Hsp90 inhibitors were effective in treating aggressive prostate cancer. The drug could target a network of cancer cell signals simultaneously.